Columbia University
Suffern, NY, United States
Dr. Felicia Cosman is a clinical scientist, endocrinologist and osteoporosis specialist. She is Professor of Medicine, Emerita, at Columbia University and has been NA Co-Editor in Chief of the journal Osteoporosis International since 2016. She received a BA from Cornell, MD from Stony Brook, and completed internship, residency and endocrinology fellowship at Columbia University College of P&S. She received the ACE Distinction in Endocrinology Award in 2019 and the ASBMR Bartter Award for clinical research in September 2020. Dr. Cosman has had many grants from NIH, DOD, foundations and industry, and has published over 190 peer-reviewed papers and over 50 book chapters. The main focus of her research has the use of anabolic medications and treatment sequencing. Dr. Cosman has investigated the effect of teriparatide on biochemical and densitometric outcomes, bone strength by FEA, and cellular action using bone biopsy. She studied the effect of teriparatide on bone formation in the human femur in patients undergoing hip arthroplasty and performed a series of studies investigating cyclic, combination and sequential regimens of teriparatide with antiresorptives. Dr. Cosman has been a primary investigator on many studies evaluating efficacy of abaloparatide and romosozumab treatment for osteoporosis. She is well known for work on optimizing anabolic treatment regimens, longterm treatment strategies, and implementing therapeutic goals for osteoporosis management.
Disclosure information not submitted.
Friday, November 11, 2022
6:00 PM – 6:40 PM Eastern Time
Sunday, November 13, 2022
10:50 AM – 11:10 AM Eastern Time
